Literature DB >> 16170389

Differentiation of tumours of ductal and lobular origin: I. Proteomics of invasive ductal and lobular breast carcinomas.

Gulisa Turashvili1, Jan Bouchal, George Burkadze, Zdenek Kolár.   

Abstract

The vast majority of invasive breast tumors are ductal and lobular breast carcinomas. Despite the many similarities, some clinical follow-up data and the patterns of metastases suggest that these histological subtypes of breast cancer are biologically distinct. Few papers, however, describe immunohistochemical markers useful for differentiation of these carcinomas. Many investigations suggest that E cadherin protein expression is lost in lobular but not in ductal carcinoma. The absence of E-CD, as a partial loss of epithelial differentiation, may account for the extended spread of lobular carcinoma in situ and the peculiar diffuse invasion mode of invasive lobular carcinoma. Some investigations report the significance of E-CD associated proteins alpha-, beta-, gamma-catenin expression, as well as the usefulness of cytokeratins 5, 6, 8, 7 and thrombospondin in differentiating histological types of breast invasive carcinomas. Several reports have suggested the possibility that invasive ductal and lobular cancers differ with respect to expression of antigens involved in proliferation and cell cycle regulation. It has been shown that vascular endothelial growth factor expression, also the expression of maspin, a tumour suppressor gene product, is higher in ductal, than in lobular carcinoma. Expression of NKX3.1, a member of the NK-class of homeodomain, is highly restricted and is found primarily in lobular carcinoma. Some histological and immunohistochemical characteristics of pleomorphic lobular carcinoma are also discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16170389     DOI: 10.5507/bp.2005.005

Source DB:  PubMed          Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub        ISSN: 1213-8118            Impact factor:   1.245


  5 in total

1.  Role of DCE-MR in predicting breast cancer subtypes.

Authors:  Marco Macchini; Martina Ponziani; Andrea Prochowski Iamurri; Mirco Pistelli; Mariagrazia De Lisa; Rossana Berardi; Gian Marco Giuseppetti
Journal:  Radiol Med       Date:  2018-06-05       Impact factor: 3.469

Review 2.  Comprehensive Review of Molecular Mechanisms and Clinical Features of Invasive Lobular Cancer.

Authors:  Nikhil Pramod; Akanksha Nigam; Mustafa Basree; Resham Mawalkar; Saba Mehra; Neelam Shinde; Gary Tozbikian; Nicole Williams; Sarmila Majumder; Bhuvaneswari Ramaswamy
Journal:  Oncologist       Date:  2021-03-16

3.  Discoidin Domain Receptor 2 Expression as Worse Prognostic Marker in Invasive Breast Cancer.

Authors:  Irene Romayor; Marina Luque García-Vaquero; Joana Márquez; Beatriz Arteta; Ramón Barceló; Aitor Benedicto
Journal:  Breast J       Date:  2022-03-07       Impact factor: 2.269

4.  p120-Catenin Is Critical for the Development of Invasive Lobular Carcinoma in Mice.

Authors:  Milou Tenhagen; Sjoerd Klarenbeek; Tanya M Braumuller; Ilse Hofmann; Petra van der Groep; Natalie Ter Hoeve; Elsken van der Wall; Jos Jonkers; Patrick W B Derksen
Journal:  J Mammary Gland Biol Neoplasia       Date:  2016-07-13       Impact factor: 2.673

5.  High-frequency deregulated expression of Wnt signaling pathway members in breast carcinomas.

Authors:  Zahid Khan; Maha Arafah; Jilani Purusottapatnam Shaik; Alka Mahale; Mohammad Saud Alanazi
Journal:  Onco Targets Ther       Date:  2018-01-11       Impact factor: 4.147

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.